Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases
- 15 January 2013
- journal article
- case report
- Published by Springer Science and Business Media LLC in Acta Neurochirurgica
- Vol. 155 (3), 407-413
- https://doi.org/10.1007/s00701-012-1611-y
Abstract
About 90 % of meningiomas are benign (WHO grade I), atypical and anaplastic variants exist (WHO grade II/III, 10 %). Tumour grade has important implications for management. Non-invasive diagnosis of tumour grade is still not feasible. The purpose of this survey was to analyse epidemiological risk factors such as sex, age and location for a higher grade (WHO grade II/III) meningioma in a large surgical series. A retrospective study comprising 1,663 patients operated on for an intracranial meningioma in a single tertiary-care centre. The population was analysed for correlations including WHO grade, histological subtype, tumour localisation, patient age and gender. Additionally correlations between Ki67 index/WHO grade and localisation were analysed. A binary logistic regression analysis revealed non-skull base localisation (OR 1.779 [CI 1.069–2.960, p = 0.0027]) and age ≥65 years (OR 1.549 [CI 1.214–2.624, p = 0.012]) as significant risk factors for a higher WHO grade. Male gender showed a trend for a higher risk in χ2 analysis. An analysis of the Ki67 index revealed an increased index for non-skull base localisation compared with skull base (p < 0.001). Correlation analysis of Ki67 distribution in WHO grade I meningiomas revealed higher Ki67 indices for non skull base localisation (p = 0.0024). Non-skull base localisation and age ≥65 years are independent risk factors for higher grade meningiomas. In other terms, the malignant potential of skull base meningiomas is low. This information is important when advising a patient about individual treatment options (observation, surgery or radio-surgery) and prognosis.Keywords
This publication has 32 references indexed in Scilit:
- Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%International Journal of Cancer, 2011
- Reproductive Factors and Exogenous Hormone Use in Relation to Risk of Glioma and Meningioma in a Large European Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2010
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Exogenous sex hormone use and risk of meningioma: a population-based case–control study in FinlandCancer Causes & Control, 2010
- Clinicopathologic Features of Aggressive Meningioma Emphasizing the Role of Radiotherapy in TreatmentStrahlentherapie und Onkologie, 2006
- Clinical and radiological features related to the growth potential of meningiomaNeurosurgical Review, 2006
- Lack of genetic and epigenetic changes in meningiomas without NF2 lossThe Journal of Pathology, 2005
- MeningiomasThe Lancet, 2004
- Preoperative identification of meningiomas that are highly likely to recurJournal of Neurosurgery, 1999
- Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcomeSurgical Neurology, 1986